Pharmaceutical News

RSS
No to over the counter statin!

No to over the counter statin!

Alvesco now available for asthma sufferers in the United Kingdom

Alvesco now available for asthma sufferers in the United Kingdom

Biopharmaceutical market generated revenues of USD 45.0 billion in 2004

Biopharmaceutical market generated revenues of USD 45.0 billion in 2004

FDA licenses Sanofi pasteur vaccine for protection against meningococcal disease

FDA licenses Sanofi pasteur vaccine for protection against meningococcal disease

Avastin available across Europe within the next few weeks

Avastin available across Europe within the next few weeks

Committees will weigh up COX-2 benefits and risks

Committees will weigh up COX-2 benefits and risks

Evaluation of BAY 43-9006 (Sorafenib) for pancreatic cancer

Evaluation of BAY 43-9006 (Sorafenib) for pancreatic cancer

MHRA and FDA to inspect Chiron's Liverpool manufacturing facility

MHRA and FDA to inspect Chiron's Liverpool manufacturing facility

Major partnership with National Institute of Allergy and Infectious Diseases for Narhex Life Sciences

Major partnership with National Institute of Allergy and Infectious Diseases for Narhex Life Sciences

Research breakthrough in treatment of TB and MDR-TB

Research breakthrough in treatment of TB and MDR-TB

Myriad Genetics initiates phase 3 clinical trial of Flurizan

Myriad Genetics initiates phase 3 clinical trial of Flurizan

Amarin announces positive results from studies using Miraxion to treat unresponsive depression

Amarin announces positive results from studies using Miraxion to treat unresponsive depression

Escalating demand for novel and effective therapeutic approaches underlines growing appeal of peptides

Escalating demand for novel and effective therapeutic approaches underlines growing appeal of peptides

Safety established for Vaxin's first flu vaccine in clinical trial

Safety established for Vaxin's first flu vaccine in clinical trial

Campral, first new treatment for alcoholism in ten years

Campral, first new treatment for alcoholism in ten years

Molecular Devices introduces fatty acid uptake assay to target metabolic diseases

Molecular Devices introduces fatty acid uptake assay to target metabolic diseases

Potential new therapies for cancer and bleeding disorders

Potential new therapies for cancer and bleeding disorders

Velcade (bortezomib) phase III clinical trial initiated in patients with newly diagnosed multiple myeloma

Velcade (bortezomib) phase III clinical trial initiated in patients with newly diagnosed multiple myeloma

Ranbaxy files anti-retrovirals (ARVs) to the U.S. FDA

Ranbaxy files anti-retrovirals (ARVs) to the U.S. FDA

Serono announces the availability of Saizen for adult growth hormone deficiency

Serono announces the availability of Saizen for adult growth hormone deficiency

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.